Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kunapa Iam-Arunthai"'
Autor:
Kunapa Iam-Arunthai, Supat Chamnanchanunt, Pravinwan Thungthong, Anongnart Chinapha, Chajchawan Nakhahes, Tawatchai Suwanban, Tsukuru Umemura
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
ObjectiveThis study aimed to evaluate the relationship between high-sensitivity C-reactive protein (hsCRP) in hospitalized COVID-19 patients and their clinical outcomes, including trajectory of hsCRP changes during hospitalization.Method and resultsP
Externí odkaz:
https://doaj.org/article/f7f9014258da4dce930cc96d28de8499
Autor:
Kunapa Iam-arunthai, Tawatchai Suwanban, Pravinwan Thungthong, Supat Chamnanchanunt, Suthat Fucharoen
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
BackgroundThalassemia is a genetic hemoglobinopathy in which a defective globin chain can cause transfusion-dependent anemia and other complications. As genotype interactions lead to variations in the clinical course among patients with thalassemia,
Externí odkaz:
https://doaj.org/article/b39e6db10f134fec99b3c80fdc366043
Autor:
Kunapa Iam-Arunthai, Supat Chamnanchanunt, Pravinwan Thungthong, Poj Intalapaporn, Chajchawan Nakhahes, Tawatchai Suwanban, Ponlapat Rojnuckarin
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 5, p 1437 (2024)
Background: Internationally established guidelines mention pharmacological prophylaxis for all hospitalized COVID-19 patients. However, there are concerns regarding the efficacy and safety of anticoagulants. This study investigated the associations b
Externí odkaz:
https://doaj.org/article/6b3fc53e005d40c6ad17ce4a3f9348c9
Autor:
Tawatchai Suwanban, Supat Chamnanchanunt, Pravinwan Thungthong, Chajchawan Nakhahes, Kunapa Iam‐arunthai, Tananchai Akrawikrai, Udomsak Bunworasate
Publikováno v:
Cancer Reports, Vol 6, Iss 8, Pp n/a-n/a (2023)
Abstract Background The survival rate of adult patients with Hodgkin lymphoma (HL) depends on the responses to standard chemotherapy, radiotherapy, or combined therapy. Resource‐limited countries face numerous obstacles in supporting patients with
Externí odkaz:
https://doaj.org/article/82fb85624e7e49b8916e968b1328f1d2
Autor:
Pravinwan Thungthong, Supat Chamnanchanunt, Tawatchai Suwanban, Chajchawan Nakhahes, Kunapa Iam-arunthai, Tananchai Akrawikrai, Udomsak Bunworasate, Ponlapat Rojnuckarin
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundA tool for estimating risk of febrile neutropenia (FN) after chemotherapy, namely the FEbrile Neutropenia after ChEmotherapy (FENCE) score, has been developed but has not been widely validated. This study aimed to validate the FENCE score a
Externí odkaz:
https://doaj.org/article/968a513130054f679533a79ec7057edb
Autor:
Tawatchai Suwanban, Supat Chamnanchanunt, Pravinwan Thungthong, Chajchawan Nakhahes, Kunapa Iam‐arunthai, Tananchai Akrawikrai, Udomsak Bunworasate
Publikováno v:
Cancer Reports.
Autor:
Kunapa Iam-arunthai, Supat Chamnanchanunt, Pravinwan Thungthong, Chajchawan Nakhahes, Tawatchai Suwanban, Ponlapat Rojnuckarin
Publikováno v:
Frontiers in Hematology. 2
PurposeRecent studies suggested that adding other agents to corticosteroids as a first-line treatment for immune thrombocytopenia (ITP) could improve outcomes. However, combination regimens may increase side effects and costs. To determine clinical f
Autor:
Supat Chamnanchanunt, Tawatchai Suwanban, Pravinwan Thungthong, Kunapa Iam-arunthai, Chajchawan Nakhakes
Publikováno v:
Asian Biomedicine. 9:697-700
Background A Janus kinase 2 (JAK2) mutation polycythemia vera (PV) is a common manifestation of stem cell disorder. However, available data on the clinical and treatment response of JAK2-negative PV patients are limited. Objectives We report the case
Autor:
Tawatchai Suwanban, Chajchawan Nakhakes, Pravinwan Thungthong, Kunapa Iam-arunthai, Supat Chamnanchanunt, Maleerat Sutherat, Napat Sukgasi
Publikováno v:
Asian Biomedicine. 8:425-428
Background: Primary granulocytic sarcoma (GS) only rarely presents with an ovarian mass classified as extramedullary myeloid progenitor tumor cells. Few patients with cases of primary GS survive after systemic chemotherapy. Objective: To present a ca
Autor:
Supat, Chamnanchanunt, Pravinwan, Thungthong, Chajchawan, Nakhakes, Tawatchai, Suwanban, Kunapa, Iam-arunthai
Publikováno v:
The Southeast Asian journal of tropical medicine and public health. 43(4)
This is a case report of a patient with chronic myeloid leukemia (CML) undergoing imatinib treatment who became infected with dengue virus. The patient presented with classic dengue symptoms, along with early minor bleeding (blood-stained sputum) dur